|
|
|
| Recombinant Adenovirus Vector Mediated Expression of HCMV UL49 Gene in Mice |
| YANG Dan,CUI Yan-wei,LI Hong-jian,LI Yue-qin,ZHOU Qi,ZENG Zhi-feng,ZHANG Xin,YANG Guang,ZHOU Tian-hong |
| National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, China |
|
|
|
Abstract Human cytomegalovirus (HCMV) is extremely species specific and does not replicate in experimental animal tissues.To overcome the problem and establish suitable animal models for studying antiviral strategies, the expression of HCMV UL49 gene was explored in mice. UL49-GFP gene was subcloned into the adenovirus shuttle plasmid pDC316, the products(pDC316-UL49-GFP)were co-transfected with helper plasmid-pBHGloxΔE1,3Cre into HEK293 cell lines by liposome reagent, recombinant adenovirus(Ad-UL49-GFP) was generated and confirmed by PCR and Western blot. Ad-UL49-GFP was propagated in 293 cells and purified. The titer of viral stocks was determined by end-point dilution assay. The purified adenoviruses were delivered into mice via the tail vein injection. Fluorescence quantitative PCR and Western blot experiments were used to examine the tissue distribution and duration of UL49 gene expression. The results showed that the recombinant adenovirus were present in vivo. The expression level in tissues arranged in descending order was liver, spleen, kidney, heart and lung . 3 days after injection, the liver, spleen, kidney, heart and lung expressed protein UL49 in high lever and then declined gradually. 14 days after injection, UL49 protein expression was disappear in some organs except liver and spleen. In conclusion, transgene animal model carrying UL49 gene was successfully established. Therefore, the system may be suitable for selecting anti-HCMV drugs targeting UL49 gene.
|
|
Received: 12 October 2009
Published: 27 January 2010
|
|
Cite this article:
YANG Dan, CUI Yan-Wei, LI Hong-Jian, LI Ru-Qin, ZHOU Qi, CENG Zhi-Feng, ZHANG Xin, YANG Guang, ZHOU Tian-Hong. Recombinant Adenovirus Vector Mediated Expression of HCMV UL49 Gene in Mice. China Biotechnology, 2010, 30(01): 1-6.
URL:
https://manu60.magtech.com.cn/biotech/ OR https://manu60.magtech.com.cn/biotech/Y2010/V30/I01/1
|
|
|
| ［1］ Walter D,Cassie C,Hong L,et al. Functional profiling of a human cytomegalovirus genome.PNAS,2003,100(24): 1422314228.
［2］ Martin S, Hans W D, Jindrich C. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence.Trends in Microbiology, 2003,11(4): 171178.
［3］ Andrew J D, Aidan D,Parvis A,et al. The human cytomegalovirus genome revisited:comparison with the chimpanzee cytomegalovirus genome. Journal of General Virology,2003,84(1):1728.
［4］ Mocarski E S, Courcelle C T. Cytomegaloviruses and their replication. In: Knipe D M, Howley P M. Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2001. 26292674.
［5］ Kern E R. Pivotal roles of animal models in the development of new therapies for cytomegalovirus infections .Antiviral Res, 2006, 71(23):164171.
［6］ Bidanset D J, Rybak R J, Hartline C B, et al. Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. Infect Dis,2001,184(2):192195.
［7］ DiLoreto Jr D,Epstein L G, Lazar E S, et al. Cytomegalovirus infection of human retinal tissue:an in vivo model. Lab Invest, 1994,71(1):141148.
［8］ Kern E R,Rybak R J,Hartline C B, et al. Predictive efficacy of SCIDhu mouse models for treatment of human cytomegalovirus infections. Antivir Chem Chemother ,2001,12(Suppl 1):149156.
［9］ Mocarski E S,Bonyhadi M,Salimi S, et al.Human cytomegalovirus in a SCIDhu mouse: thymic epithelial cells are prominent targets of viral replication. PNAS, 1993, 90(1):104108.
［10］ Weber O,Bender W,Eckenberg P, et al. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel nonnucleosidic compound in vivo. Antiviral Res, 2001,49(3):179189.
［11］ Centra M, Ratych R E,Cao G L, et al. Culture of bovine pulmonary artery endothelial cells on Gelfoam blocks. FASEB J, 1992,6(2):31173121.
［12］ Zhang W W.Development and application of adenoviral vetors for gene theraphy of cancer. Cancer Gene Ther, 1999,6(2):113138.
［13］ Flotte T R,Cater B J. Adenoassociated virus vectors for gene therapy. Gene Ther,1995,2(6):357362.
［14］ Ng P, Parks R J, Cummings D T, et al. A high efficiency Cre / loxp based system for construction of adenoviralvectors. Hum Gene Ther, 1999, 10 (16):2667 2672. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
